Our Story

Be Informed. Be Smart. Be Sure.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean feugiat dictum lacus, ut hendrerit mi pulvinar vel. Fusce id nibh at neque eleifend tristique at sit amet libero. In aliquam in nisl nec sollicitudin. Sed consectetur volutpat sem vitae facilisis. Fusce tristique, magna ornare facilisis sagittis, tortor mi auctor libero, non pharetra sem ex eu felis. Aenean egestas ut purus nec vehicula. Morbi eu nisi erat. Nam mattis id lectus sit amet mattis. Suspendisse eget tristique neque

Working Hours

Monday - Friday 09:00AM-17:00PM
Saturday - Sunday CLOSED

Latest News

    No posts were found.





  • Project feasibility
  • Study start up
  • Protocol and IB development
  • Monitoring
  • Site management
  • Clinical trial coordination
  • Project management
  • Site close out

Patient recruitment

  • Patient identification (due diligence)
  • Patient recruitment and retention
  • Comprehensive prescreening
  • Phone appointment system
  • Study site training
  • Money back guarantee

Quality Management

  • Investigator site audits
  • Quality system management
  • Vendor audits:
    • Good clinical laboratory practice (GCLP)
    • IP distribution and storage facilities
    • Central laboratories
    • Archive facilities
    • Bio-repositories
    • Bio-analytical laboratories
  • GLP and GCP audits
  • SOP development
  • Computerised system audits (CTMS, eTMF and EDC)

Data Management and Statistics


  • Input into protocol design
  • Sample size calculations
  • Development of statistical analysis plans
  • Programming of tables, listings and figures
  • Statistical analysis (interim and final)
  • Publishing of statistical reports
  • General statistical advice on efficacy and patient safety

Data Management

  • CRF design and development
  • Edit check programming
  • Data cleaning and validation
  • Laboratory and third party data integration and reconciliation
  • Medical coding
  • Provision of CDISC compliant SDTM and ADaM datasets
  • ePatient report outcomes (ePRO)
  • End point adjudication
  • Risk based monitoring (RBM)

Medical writing

  • Medical writing
  • Medical writing of protocols, IB and CSRs to ICH-GCP standards
  • Endpoint development and evaluation
  • Input into pharmacokinetic and pharmacodynamic considerations
  • Statistical analysis and interpretation
  • Review and reporting of safety information
  • Promotional material review


  • Regulatory strategy development:
    • Regulatory due diligence and gap analysis
    • Dossier evaluation
    • Competitive intelligence
    • Pre-submission and resubmission meetings
    • Bioequivalence and clinical strategies
  • Submissions for: new chemical entities, new biological medicines, generics, biosimilars, OTC and medical devices

Australian R&D Tax Incentive when Conducting Research in Australia

The Research and development (R&D) tax incentive encourages companies to engage in R&D benefiting Australia, by providing a tax offset for eligible R&D activities.

The R&D tax incentive replaced the R&D tax concession from 1 July 2011 and applies differently from the concession.

In principal, the tax incentive has been developed to promote R&D in the industry that otherwise may not have been conducted. The incentive allows for more predictability which allows for small and mid-sized companies to engage easier in R&D in Australia.

Complete Phase Consulting can provide you with a local R&D tax expert who can discuss the requirements to qualify for these incentives and help you every step of the way.